Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activation

Alcohol

Volumn 41, Issue 4, 2007, Pages 271-280

  Horiguchi, Norio ^a   Ishac, Edward J N ^b   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol; Cell proliferation; Cirrhosis; HCV; Liver regeneration; STAT3

Indexed keywords

ALCOHOL; KI 67 ANTIGEN; STAT3 PROTEIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER INJURY; LIVER REGENERATION; MALE; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ADULT; AGED; ALBUMINS; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILE DUCTS; BILIRUBIN; BIOTRANSFORMATION; CELL PROLIFERATION; CREATININE; FEMALE; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIVER CIRRHOSIS, ALCOHOLIC; LIVER REGENERATION; MALE; MIDDLE AGED; STAT3 TRANSCRIPTION FACTOR;

HEPATITIS C VIRUS;

EID: 34447284943     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2007.04.008     Document Type: Article

References (43)

1. Arteel G.E. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124 (2003) 778-790
2. Cardin R., D'Errico A., Fiorentino M., Cecchetto A., Naccarato R., and Farinati F. Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease. Alcohol Alcohol. 37 (2002) 43-48
3. Chen J., Bao H., Sawyer S., Kunos G., and Gao B. Effects of short and long term ethanol on the activation of signal transducer and activator transcription factor 3 in normal and regenerating liver. Biochem. Biophys. Res. Commun. 239 (1997) 666-669
4. Chen J., Clemens D.L., Cederbaum A.I., and Gao B. Ethanol inhibits the JAK-STAT signaling pathway in freshly isolated rat hepatocytes but not in cultured hepatocytes or HepG2 cells: evidence for a lack of involvement of ethanol metabolism. Clin. Biochem. 34 (2001) 203-209
5. Chen J., Kunos G., and Gao B. Ethanol rapidly inhibits IL-6-activated STAT3 and C/EBP mRNA expression in freshly isolated rat hepatocytes. FEBS Lett. 457 (1999) 162-168
6. Clouston A.D., Powell E.E., Walsh M.J., Richardson M.M., Demetris A.J., and Jonsson J.R. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 41 (2005) 809-818
7. Crary G.S., and Albrecht J.H. Expression of cyclin-dependent kinase inhibitor p21 in human liver. Hepatology 28 (1998) 738-743
8. Delhaye M., Louis H., Degraef C., Le Moine O., Deviere J., Gulbis B., Jacobovitz D., Adler M., and Galand P. Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis. Hepatology 23 (1996) 1003-1011
9. Dey A., and Cederbaum A.I. Alcohol and oxidative liver injury. Hepatology 43 (2006) S63-S74
10. Diehl A.M., Chacon M., and Wagner P. The effect of chronic ethanol feeding on ornithine decarboxylase activity and liver regeneration. Hepatology 8 (1988) 237-242
11. Farinati F., Cardin R., D'Errico A., De Maria N., Naccarato R., Cecchetto A., and Grigioni W. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology 23 (1996) 1468-1475
12. Farinati F., Cardin R., Fiorentino M., D'Errico A., Grigioni W., Cecchetto A., and Naccarato R. Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease. J. Viral Hepat. 8 (2001) 34-40
13. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39 (2004) 1477-1487
14. Fausto N., Campbell J.S., and Riehle K.J. Liver regeneration. Hepatology 43 (2006) S45-S53
15. Gao B. Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure. Alcohol 34 (2004) 59-65
16. Gao B. Cytokines, STATs and liver disease. Cell. Mol. Immunol. 2 (2005) 92-100
17. Gong G., Waris G., Tanveer R., and Siddiqui A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl. Acad. Sci. USA 98 (2001) 9599-9604
18. Haga S., Terui K., Zhang H.Q., Enosawa S., Ogawa W., Inoue H., Okuyama T., Takeda K., Akira S., Ogino T., et al. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J. Clin. Invest. 112 (2003) 989-998
19. Hong F., Kim W.H., Tian Z., Jaruga B., Ishac E., Shen X., and Gao B. Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 21 (2002) 32-43
20. Hong F., Radaeva S., Pan H.N., Tian Z., Veech R., and Gao B. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 40 (2004) 933-941
21. Isomoto H., Kobayashi S., Werneburg N.W., Bronk S.F., Guicciardi M.E., Frank D.A., and Gores G.J. Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells. Hepatology 42 (2005) 1329-1338
22. Isomoto H., Mott J.L., Kobayashi S., Werneburg N.W., Bronk S.F., Haan S., and Gores G.J. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing. Gastroenterology 132 (2007) 384-396
23. Jeong W.I., Park O., Radaeva S., and Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 44 (2006) 1441-1451
24. Kawamura H., Govindarajan S., Aswad F., Machida K., Lai M.M., Sung V.M., and Dennert G. HCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice. Hepatology 44 (2006) 936-944
25. Koteish A., Yang S., Lin H., Huang J., and Diehl A.M. Ethanol induces redox-sensitive cell-cycle inhibitors and inhibits liver regeneration after partial hepatectomy. Alcohol Clin. Exp. Res. 26 (2002) 1710-1718
26. Larrea E., Aldabe R., Molano E., Fernandez-Rodriguez C.M., Ametzazurra A., Civeira M.P., and Prieto J. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies. Gut 55 (2006) 1188-1196
27. Lee F.Y., Lu R.H., Tsai Y.T., Lin H.C., Hou M.C., Li C.P., Liao T.M., Lin L.F., Wang S.S., and Lee S.D. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation. Scand. J. Gastroenterol. 31 (1996) 500-505
28. Li W., Liang X., Kellendonk C., Poli V., and Taub R. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J. Biol. Chem. 277 (2002) 28411-28417
29. Lumeng L., and Crabb D.W. Alcoholic liver disease. Curr. Opin. Gastroenterol. 17 (2001) 211-220
30. Lunz III J.G., Tsuji H., Nozaki I., Murase N., and Demetris A.J. An inhibitor of cyclin-dependent kinase, stress-induced p21(Waf-1/Cip-1), mediates hepatocyte mito-inhibition during the evolution of cirrhosis. Hepatology 41 (2005) 1262-1271
31. Michalopoulos G.K., and DeFrances M. Liver regeneration. Adv. Biochem. Eng. Biotechnol. 93 (2005) 101-134
32. Orrego H., Crossley I.R., Saldivia V., Medline A., Varghese G., and Israel Y. Long-term ethanol administration and short- and long-term liver regeneration after partial hepatectomy. J. Lab. Clin. Med. 97 (1981) 221-230
33. Pan H., Hong F., Radaeva S., and Gao B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell. Mol. Immunol. 1 (2004) 43-49
34. Purohit V., and Brenner D.A. Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium. Hepatology 43 (2006) 872-878
35. Radaeva S., Sun R., Pan H.N., Hong F., and Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39 (2004) 1332-1342
36. Starkel P., De Saeger C., Leclercq I., Strain A., and Horsmans Y. Deficient Stat3 DNA-binding is associated with high Pias3 expression and a positive anti-apoptotic balance in human end-stage alcoholic and hepatitis C cirrhosis. J. Hepatol. 43 (2005) 687-695
37. Sun R., Park O., Horiguchi N., Kulkarni S., Jeong W.I., Sun H.Y., Radaeva S., and Gao B. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice. Hepatology 44 (2006) 955-966
38. Sun Z., Klein A.S., Radaeva S., Hong F., El-Assal O., Pan H.N., Jaruga B., Batkai S., Hoshino S., Tian Z., et al. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 125 (2003) 202-215
39. Tsukamoto H., and Lu S.C. Current concepts in the pathogenesis of alcoholic liver injury. Faseb. J. 15 (2001) 1335-1349
40. Wands J.R., Carter E.A., Bucher N.L., and Isselbacher K.J. Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology 77 (1979) 528-531
41. Williams R. Global challenges in liver disease. Hepatology 44 (2006) 521-526
42. Wolk K., and Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 17 (2006) 367-380
43. Zhang B.H., Hornsfield B.P., and Farrell G.C. Chronic ethanol administration to rats decreases receptor-operated mobilization of intracellular ionic calcium in cultured hepatocytes and inhibits 1,4,5-inositol trisphosphate production: relevance to impaired liver regeneration. J. Clin. Invest. 98 (1996) 1237-1244